MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.
Loading...
Loading...
This medium-severity CVE scores 6.1 under NVD CVSS v3. EPSS exploit probability: 3.7%, top 12% of all CVEs by exploit prediction. GitHub Security Advisory data not yet ingested — confidence will rise once GHSA publishes (typical lag: hours to days for open-source ecosystem CVEs; never for infrastructure-only CVEs).
MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.
January 19, 2024
November 28, 2025
| Package | Vulnerable range | Fixed in | Dependents |
|---|---|---|---|
| de.ipb-halle:molecularfaces | 0.2.0 | 0.3.0 | — |
MITRE Common Weakness Enumeration — the root-cause categories this CVE belongs to.
Every time one of our enrichment pipelines (NVD, MITRE cvelistV5, EPSS, CISA KEV, GHSA, OSV, vendor advisories) ran against this CVE. Most recent first.
See which npm, PyPI, Go, and Maven packages are affected by CVE-2024-0758
EchelonGraph automatically scans your cloud infrastructure and maps CVE exposure using blast radius analysis.